-+ 0.00%
-+ 0.00%
-+ 0.00%

Enliven Therapeutics Chief Scientific Officer Joseph P. Lyssikatos Reports Disposal of Common Shares

Reuters·02/10/2026 23:12:41

Please log in to view news